Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 6/20 | 0.49 |
| ▸ | RAB9A | P51151 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | CCR2 | P41597 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17029148 | 0.95 | L3MBTL1 (0.65) | L3MBTL1HTTKMT2AMEN1LMNA | |
| SCHEMBL16707655 | 0.92 | MAPT (0.60) | L3MBTL1HTTKMT2AMEN1LMNA | |
| SCHEMBL17029177 | 0.89 | HTT (0.57) | L3MBTL1HTTKMT2AMEN1LMNA | |
| SCHEMBL17029149 | 0.86 | HTT (0.67) | L3MBTL1HTTKMT2AMEN1LMNA | |
| SCHEMBL17029153 | 0.84 | HTT (0.62) | L3MBTL1HTTKMT2AMEN1LMNA | |
| SCHEMBL17029151 | 0.84 | HTT (0.62) | L3MBTL1HTTKMT2AMEN1LMNA | |
| SCHEMBL17029175 | 0.84 | LMNA (0.70) | L3MBTL1HTTKMT2AMEN1LMNA | |
| SCHEMBL17029145 | 0.84 | LMNA (0.76) | L3MBTL1HTTKMT2AMEN1LMNA | |
| SCHEMBL17029163 | 0.83 | HTT (0.63) | L3MBTL1HTTKMT2AMEN1LMNA | |
| SCHEMBL16707656 | 0.83 | MAPT (0.65) | L3MBTL1HTTKMT2AMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9115113-B2 | Azepane derivatives and methods of treating hepatitis B infections | NOVIRA THERAPEUTICS, INC. (US) | 2015-08-25 | — | — | US | disclosed |